Torrent Pharmaceuticals Limited (BOM:500420)
5,017.05
+57.25 (1.15%)
At close: Jul 27, 2026
Torrent Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 29 analysts polled by S&P Global, Torrent Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹4,912. The average 1-year stock price forecast is 2.09% lower than the current stock price, while the lowest is ₹4,050 (-19.28%) and the highest is ₹5,423 (+8.09%).
Price Target: ₹4,912 (-2.09%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Torrent Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 15 | 16 | 16 | 16 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 5 | 5 | 6 | 5 | 6 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 28 | 28 | 28 | 29 | 29 |
Financial Forecast
Revenue This Year
190.46B
from 139.80B
Increased by 36.24%
Revenue Next Year
214.06B
from 190.46B
Increased by 12.39%
EPS This Year
68.88
from 65.88
Increased by 4.56%
EPS Next Year
93.97
from 68.88
Increased by 36.42%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.